Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AVITA Medical (RCEL) Accumulated Expenses (2019 - 2025)

Historic Accumulated Expenses for AVITA Medical (RCEL) over the last 7 years, with Q4 2025 value amounting to -$2.6 million.

  • AVITA Medical's Accumulated Expenses fell 20641.39% to -$2.6 million in Q4 2025 from the same period last year, while for Dec 2025 it was -$2.6 million, marking a year-over-year decrease of 20641.39%. This contributed to the annual value of -$2.6 million for FY2025, which is 20641.39% down from last year.
  • AVITA Medical's Accumulated Expenses amounted to -$2.6 million in Q4 2025, which was down 20641.39% from $5.8 million recorded in Q3 2025.
  • Over the past 5 years, AVITA Medical's Accumulated Expenses peaked at $9.8 million during Q3 2024, and registered a low of -$2.6 million during Q4 2025.
  • In the last 5 years, AVITA Medical's Accumulated Expenses had a median value of $5.6 million in 2021 and averaged $5.2 million.
  • As far as peak fluctuations go, AVITA Medical's Accumulated Expenses surged by 5833.56% in 2024, and later plummeted by 20641.39% in 2025.
  • AVITA Medical's Accumulated Expenses (Quarter) stood at $5.4 million in 2021, then rose by 23.49% to $6.6 million in 2022, then increased by 20.37% to $8.0 million in 2023, then plummeted by 68.9% to $2.5 million in 2024, then plummeted by 206.41% to -$2.6 million in 2025.
  • Its Accumulated Expenses stands at -$2.6 million for Q4 2025, versus $5.8 million for Q3 2025 and $7.9 million for Q2 2025.